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Abstract: Thyme (TO), cinnamon (CO), and Ceylon type lemongrass (LO) essential oils (EOs) are
commonly used for inhalation. However, their effects and mechanisms on inflammatory processes
are not well-documented, and the number of in vivo data that would be important to determine
their potential benefits or risks is low. Therefore, we analyzed the chemical composition and
investigated the activity of TO, CO, and LO on airway functions and inflammatory parameters
in an acute pneumonitis mouse model. The components of commercially available EOs were
measured by gas chromatography–mass spectrometry. Airway inflammation was induced by
intratracheal endotoxin administration in mice. EOs were inhaled during the experiments. Airway
function and hyperresponsiveness were determined by unrestrained whole-body plethysmography
on conscious animals. Myeloperoxidase (MPO) activity was measured by spectrophotometry from
lung tissue homogenates, from which semiquantitative histopathological scores were assessed.
The main components of TO, CO, and LO were thymol, cinnamaldehyde, and citronellal, respectively.
We provide here the first evidence that TO and CO reduce inflammatory airway hyperresponsiveness
and certain cellular inflammatory parameters, so they can potentially be considered as adjuvant
treatments in respiratory inflammatory conditions. In contrast, Ceylon type LO inhalation might
have an irritant effect (e.g., increased airway hyperresponsiveness and MPO activity) on the inflamed
airways, and therefore should be avoided.
Keywords: thyme; lemongrass; cinnamon; essential oil; endotoxin; airway inflammation; mouse
model; airway hyperresponsiveness; myeloperoxidase activity; perivascular edema
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1. Introduction
Essential oils (EOs) are made up of secondary metabolites by plants. They are liquid mixtures
of various compounds (such as terpenoids and phenylpropane derivates) that evaporate at room
temperature. Their most common extraction method is distillation. Due to their characteristic aroma
and biological effects, EOs are commonly used for different purposes in the fields of aromatherapy,
food preservation, plant pathology and medical microbiology. The application of EOs is increasing
among patients as a single or adjuvant treatment for respiratory diseases and inflammations based on
traditional use and empirical evidence.
Inflammatory lung diseases affect a large population at every age worldwide, and they also
appear on the list of the top 10 causes of death [1]. These diseases are associated with acute or chronic
inflammation and deteriorate the patients′ quality of life.
The advantages of EOs are that they can easily reach the respiratory tract via inhalation due to
their volatility, and because of their complex composition they can exert multiple actions through
the modification of lipoxygenase, cyclooxygenase and inducible nitric oxide synthase function as
well as the inhibition of the inflammatory mediator production [2,3]. Recent studies have proved the
anti-inflammatory effects of eucalyptus and lavender EOs, 1,8-cineole (eucalyptol), and menthol [2,4–6].
Thyme (TO), cinnamon (CO) and lemongrass (LO) EOs are commonly used via inhalation.
Their components have been shown to reduce inflammatory cytokine production and some
inflammatory parameters [7–15]. However, the results of previous studies are poorly comparable
and not conclusive, because the studies used EOs of different sources, purity and compositions,
mainly certain isolated components are studied, moreover, the experimental paradigms, investigated
parameters and the outcomes greatly differ from each other. Furthermore, there are only few in vivo
data and airway function results are even more scarcely available, which would be important to
determine their potential clinical benefits and risks, particularly under inflammatory conditions.
TO is extracted from the fresh flowering aerial parts of Thymus vulgaris L. (Lamiaceae) and other
Thymus species via steam distillation. Thymus vulgaris has several chemotypes containing different
main components such as thymol, carvacrol, linalool, and geraniol. The most prevalent use of TO is by
inhalation as an expectorant in bronchitis and common cold [16,17].
We used the EO of Cinnamomum verum J.S. Presl. (Lauraceae) as CO, isolated by steam distillation
from the bark of the shoots with trans-cinnamaldehyde, as the main component. In medieval times,
CO was used against frontal sinusitis and common cold, but nowadays, it is more commonly used for
the treatment of gastrointestinal problems [18].
LO is obtained by steam distillation from the fresh or partially dried aerial parts of Cymbopogon
species. We used the EO of Cymbopogon nardus (L.) Rendle (Poaceae, Ceylon type). Characteristic
components are citronellal, geraniol, citronellol, limonene, citronellyl acetate, geranyl acetate and neral.
The treatment of common cold is among the traditional uses of LO [19,20].
The endotoxin (lipopolysaccharide: LPS)-induced acute airway inflammation mouse model is the
most commonly used, well-reproducible mechanism model for the study of EOs in acute respiratory
inflammation [10,13,15,21]. LPS is a compound of the Gram-negative bacterial cell wall that causes
interstitial pneumonitis and acute respiratory obstruction with a well-defined mechanism by activating
Toll-like receptor-4 on macrophages, resulting in the release of several inflammatory mediators and
consequent neutrophil activation after intranasal or intratracheal administration [22].
Here, we analyzed the chemical composition of TO, CO and LO, and investigated their effects on
airway functions and inflammatory parameters in the endotoxin-induced acute pneumonitis mouse
model, which is a characterized pathophysiological mechanism model relevant to several conditions of
human lung inflammation.
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2. Results
2.1. Chemical Analysis of EOs
Chemical analysis of EOs was conducted using gas chromatography with a flame-ionization
detector (GC-FID) and GC-MS. The main components of TO were thymol (46.3%) and p-cymene
(22.1%); cinnamaldehyde was the main component (74.0%) in CO; whereas citronellal (36.2%) and
geraniol (25.3%) were present in the highest concentrations in LO (Table 1). Other significant identified
compounds included 1,8-cineole (9.8%), linalool (5.1%), and carvacrol (3.2%) in TO; cinnamyl acetate
(5.3%) and linalool (3.9%) in CO; and citronellol (13.6%), limonene (3.6%) in LO.
Table 1. The chemical composition of the investigated essential oils in percentage from 3 parallel
measurements (main components in bold).
Compound tR(min)
Thyme
(%)
Cinnamon
(%)
Lemongrass
(%)
α-Pinene 5.8 0.9 0.9 −
Camphene 6.1 0.9 − −
β−Myrcene 6.3 0.7 −
β−Pinene 6.7 1.4 0.5 −
α−Terpinene 7.0 2.2 − −
o-Cymene 7.0 0.3
p-Cymene 7.4 22.1 1.2 −
Limonene 7.5 − 1.4 3.6
1,8-Cineole 7.9 9.8 2.1 −
γ-Terpinene 8.6 0.3 − −
Linalool 10.2 5.1 3.9 −
Citronellal 10.4 − − 36.2
Terpinen-4-ol 11.7 0.6 - −
α-Terpineole 11.8 0.2 1.6 −
Citronellol 11.9 − − 13.6
Camphore 12.1 0.5 − −
Neral 12.2 − − 1.0
Geraniol 12.4 − − 25.3
Borneol 12.4 1.5 − −
Geranial 12.8 − − 2.2
Cinnamaldehyde 12.9 − 74.0 −
Anethol 13.1 − 4.5 −
Thymol 13.2 46.3 − −
Carvacrol 13.3 3.2 − −
Citronellyl acetate 14.1 − − 2.3
Eugenol 14.2 − 2.7 −
Geranyl acetate 14.5 − − 2.6
β-Elemene 14.7 0.4 − 2.9
β-Caryophyllene 15.4 2.5 1.7 −
α-Humulene 15.6 0.5 − −
β-Cubebene 15.7 − − 2.9
Cinnamyl acetate 15.8 − 5.3 −
α-Muurolene 16.6 − − 1.6
β-Cadinene 16.9 − − 3.2
Elemol 17.4 − − 2.4
Caryophyllene oxide 18.0 0.5 − −
Eudesmol 18.3 − − 2.3
Total 99.5 99.8 99.8
2.2. Respiratory Functions
LPS treatment significantly reduced the frequency, minute ventilation and relaxation time
and increased tidal volume, time of inspiration and expiration, as well as peak expiratory
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flow 24 h after administration, whereas it did not alter peak inspiratory flow (Figure 1A–H,
Figures S1 and S2). Penh correlating with airway hyperresponsiveness was remarkably increased
already at baseline measurement and was further aggravated upon carbachol inhalation-induced
bronchoconstriction in LPS-treated mice. CO and TO inhalation significantly reduced the
carbachol-induced hyperresponsiveness in LPS-treated mice compared to paraffin oil (PO) inhalation
used as a negative control, whereas LO significantly deteriorated baseline Penh (Figure 1I and Figure S1).
Regarding the other basal respiratory parameters, tidal volume was significantly reduced by LO
compared to the PO-treated LPS-administered group, but this seemingly ameliorating effect could be
the result of the lowest frequency and minute ventilation measured in all groups.
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which was not significantly increased compared to its respective phosphate-buffered saline (PBS)-
treated control. Regarding macrophage infiltration and total score, neither TO nor CO were 
significantly increased compared to their PBS-treated controls. LO did not influence the extent of 
histopathological alterations (Figure 3), although we found mild goblet cell hyperplasia, similarly to 
the LPS-treated group, and focal lymphocyte follicles after LO inhalation (data not shown). 
Figure 1. Effects of thyme (TO), cinnamon (CO) and lemongrass (LO) essential oils on (A) breathing
frequency, (B) tidal volume, (C) mi ute ve tilation, (D) ti e of inspiration, (E) time of expiration,
(F) peak inspiratory flow, (G) peak expiratory flow, (H) relaxation time and (I) Penh compared to the
negative control paraffin oil (PO), after lipopolysaccharide (LPS - black columns)/phosphate-buffered
saline (PBS - white columns) treatment. (n = 8–10/group, # p < 0.05, ## p < 0.005, ### p < 0.0005,
#### p < 0.0001 vs. respective PBS-treated group, *p < 0.05, ** p < 0.005, *** p < 0.0005, **** p < 0.0001 vs.
LPS-PO-treated mice).
2.3. Lung Histopathological Evaluation
LPS administration induced a massive inflammatory infiltration in the lung composed of neutrophil
granulocytes and macrophages associated with a remarkable perivascular and peribronchial edema
formation (Figure 2). LPS-induced edema formation was decreased by TO, which was not significantly
increased compared to its respective phosphate-buffered saline (PBS)-treated control. Regarding
macrophage infiltration and total score, neither TO nor CO were significantly increased compared to
their PBS-treated controls. LO did not influence the extent of histopathological alterations (Figure 3),
although we found mild goblet cell hyperplasia, similarly to the LPS-treated group, and focal
lymphocyte follicles after LO inhalation (data not shown).
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Figure 2. Histopathological alterations in the lung. Representative pictures of lung parenchyma after
(A) PBS and PO treatment, (B) LPS and PO treatment, (C) PBS and TO treatment, (D) LPS and TO
treatment, (E) PBS and CO treatment, (F) LPS and CO treatment, (G) PBS and LO treatment, and (H) LPS
and LO treatment. (Hematoxylin–eosin staining, 200 × magnification; a: alveolus, b: bronchiole,
v: vessel, ed: edema).
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significantly increased after LPS treatment in the lung homogenates in accordance with the 
histopathological findings. TO decreased but, surprisingly, LO inhalation further increased enzyme 
activity in the LPS-treated animals, while CO had no significant effect on this parameter (Figure 4). 
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2.4. Myeloperoxidase (MPO) Activity
MPO activity—correlating with the number of activated granulocytes and
macrophages—significantly increased after LPS treatment in the lung homogenates in accordance with
the histopathological findings. TO decreased but, surprisingly, LO inhalation further increased enzyme
activity in the LPS-treated animals, while CO had no significant effect on this parameter (Figure 4).
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3. Discussion
We provide here the first evidence that TO (with thymol and p-cymene as main compounds)
and CO (with cinnamaldehyde as main component) inhalation decrease inflammatory airway
hyperresponsiveness and histopathological alterations in the endotoxin-induced pneumonitis mouse
model. Furthermore, TO, but not CO, decreases MPO activity, as a parameter of inflammatory cell
activation as well. In contrast, LO (with citronellal and geraniol as main components) aggravates
airway responsiveness and MPO activity.
These findings are supported by earlier data showing the anti-inflammatory potential of TO with
different compositions in other airway inflammation models. Thyme and ivy extracts significantly
reversed leukocyte infiltration in a similar LPS-induced acute lung inflammation rat model [23]. In an
ovalbumin-induced chronic asthma mouse model thymol exerted a significant anti-inflammatory effect
by inhibiting inflammatory cell accumulation and reducing pro-inflammatory cytokine concentrations,
as well as ameliorating airway hyperresponsiveness and histopathological alterations in the lungs [12].
In a carrageenan-induced pleurisy rat model TO (with carvacrol as main component) and carvacrol,
but not thymol reduced leukocyte migration. However, both thymol and carvacrol had a potent
anti-edema effect [9]. We also found that TO significantly reduced edema formation, but not
inflammatory cell infiltration. This virtually contradictory result could be explained by the different
composition of TO used in our study with thymol and p-cymene as main components and only
3.2% carvacrol content. Recent data demonstrated the anti-inflammatory effect of p-cymene as
well, significantly alleviating LPS-induced acute lung inflammation, edema, TNF-α, IL-1β and IL-6
production [10,11].
There is abundant literature on the anti-inflammatory effect of cinnamaldehyde, the main
component of CO, but these studies did not investigate functional parameters. It has been described
that cinnamaldehyde inhibits the IL-1β and TNF-α production of macrophages stimulated by LPS
in vitro [7], as well as in systemic inflammatory response syndrome in vivo [14]. The EO of Rimulus
cinnamon or Guizhi (75.26% cinnamaldehyde) also decreased IL-1β, IL-18, IL-5, IF-γ, MCP-1, CSF-1 and
MIP-1β in the serum, neutrophil cell count and nitric oxide production in the lung after intraperitoneal
LPS administration [24].
LO with citral as main constituent has been described to suppress neutrophil adhesion and
activation [25], edema formation and histopathological changes, as well as pro-inflammatory cytokine
levels [13]. The anti-inflammatory property of citral is also supported by its ability to suppress
LPS-induced cyclooxygenase-2 expression in the human macrophage-like U937 cell line [26]. In another
in vitro study with macrophages LO pre-treatment in low doses significantly elevated IL-6 and IL-1β
production; moreover, LO was only able to inhibit LPS effect in high doses. However, its main
component, citral, effectively reduced cytokine levels both in pre-treatment and after LPS activation.
These findings highlight the anti-inflammatory effect of the citral component of LO [8]. LO used in this
study contained low levels of citral (neral + geranial), which can explain our results not supporting
these earlier findings. However, much fewer data are available regarding the Cymbopogon nardus
oil used in our study with citronellal and geraniol as main components. The EO of Citrus maxima
(syn. Citrus grandis, contains citronellal and citronellol) and citronellal have been described to inhibit
5-lipoxygenase activity [27]. Geraniol, the other main component of LO used in our study, reduced
MPO activity and pro-inflammatory cytokines production in vivo in an LPS-evoked acute lung injury
model [15]. Moreover, geraniol dramatically reduced the expression of Toll-like receptor 4 and
prevented nuclear factor-κB activation [15]. Our contradictory findings might also be due to the
different EO composition. Limonene, for instance, a minor component in Cymbopogon nardus was used
in our study and has been described to induce bronchoconstriction in mice [28], which could explain
the increased hyperresponsiveness elicited by our EO.
Therefore, when using the complex EOs instead of the individual components, the composition
can significantly influence their biological effects and all components can interact with each other.
For instance, 1,8-cineol, the minor TO and CO component, has some bronchodilator effects in
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guinea-pigs and rats [29,30], which can contribute to the improvement of respiratory parameters.
The anti-inflammatory effect (steroid-sparing effect) and mucolytic potential of 1,8-cineol have also been
proven in humans [31]. Myrtol, a standardized mixture of EOs containing cineole, limonene (minor
components of CO and LO) and α-pinene (minor component of TO and CO) inhibited LPS-induced
neutrophil accumulation, TNF-α, IL-6 and MPO activity increase in mice [32]. Furthermore, linalool,
the minor component of TO and CO, attenuated histopathological changes and cytokine production in
a similar model [21].
Airway inflammation is commonly accompanied by bacterial infections, therefore, the antibacterial
and antifungal effects of EOs can also be beneficial in these conditions, particularly considering the
spread of multiresistant bacteria and fungi [33–37]. We previously demonstrated the bactericidal effects
of the vapor phase of TO, CO and LO, similarly to clove and eucalyptus EOs; as well as the bacteriostatic
properties of Scots pine and peppermint EO against bacteria most common in respiratory infections
including Staphylococcus aureus, methicillin-resistant S. aureus (MRSA) and Pseudomonas aeruginosa [38].
Despite the fact that our results provide useful information regarding the potential benefits
and risks of EO inhalation in airway inflammation, a limitation of our experimental design is that
we could not measure the exact EO concentration in the inhalation box but could only calculate its
maximum value.
Considering the well-documented agonistic effects of thymol, cinnamaldehyde, carvacrol and
linalool on members of the Transient Receptor Potential (TRP) ion channel family [39,40], the effects of
these compounds might potentially be mediated by the Vanilloid 1 (TRPV1) or Ankyrin 1 (TRPA1) ion
channels. TRPA1 and TRPV1 are expressed and often co-localized on the capsaicin-sensitive peptidergic
afferents densely innervating the lung [41], as well as on pulmonary epithelial cells lymphocytes and
bronchial smooth muscle cells [42,43]. TRPA1 and TRPV1 have been reported to be protective against
the LPS-induced acute lung injury model [44–46]. The potential interactions of these essential oil
components with the TRP ion channels in the LPS-induced acute lung injury model might open future
drug developmental perspectives worth investigating.
4. Materials and Methods
4.1. EO Samples and the Gas Chromatographic Analysis of Their Composition
Cinnamon bark (Cinnamomum zeylanicum Nees. syn. Cinnamomum verum J.Presl),
thyme (Thymus vulgaris L.), and lemongrass (Cymbopogon nardus (L.) Rendle) essential oils were
bought from Aromax Ltd. (Budapest, Hungary). Gas chromatography–mass spectrometry (GC-MS,
Agilent 6890 N/5973 N GC-MSD, Santa Clara, CA, USA) was used to analyze the chemical composition
of the EO samples. The percentage composition of the EOs was evaluated with a flame ionization
detector (FID). Compounds were identified based on retention times and spectral data of standard
compounds, and the NIST 05 mass spectral library was also applied as previously described [38,47].
4.2. Animals
In the animal experiments, 10–18 week old female C57BL/6J mice [22] were used weighing
20.8 ± 0.26 g (Mean ± SEM) at the beginning of the experiment (Table S1). In order to avoid age-related
differences, the age distribution of the mice was similar in each group. They were bred and kept in the
Laboratory Animal House of the Department of Pharmacology and Pharmacotherapy at the University
of Pécs. Optimal parameters were provided for all the animals (e.g., 325 × 170 × 140 mm cages, 12 h
light/dark cycle, 24–25 ◦C, mouse chow, water).
During the experiments, the following regulations were taken into account: European legislation
(Directive 2010/63/EU) and Hungarian Government regulation (40/2013., II. 14.) on the protection of
animals used for scientific purposes, and the recommendations of the International Association for the
Study of Pain. The study design was approved by the Ethics Committee on Animal Research of the
University of Pécs (license No.: BA02/2000-26/2018, 21 June 2018).
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4.3. Induction of Acute Airway Inflammation and Groups of Animals
Animals received Escherichia coli (serotype: 083) LPS intratracheal (i.t.) (100 µg LPS dissolved
in 60 µL phosphate-buffered saline (PBS)) to induce acute airway inflammation. The endotoxin was
isolated and purified in the Department of Microbiology, University of Pécs. During the administration
of LPS, the animals were put under ketamine (100 mg/kg i.p.) and xylazine (5 mg/kg i.p.) anesthesia.
Control mice received the same volume of sterile PBS [25]. Animals were treated with EO inhalation 1 h
prior to and 4 and 23 h following LPS/PBS administration. Paraffin oil (PO) was used as negative control.
Two oil drops (0.05 mL) were applied to a filter paper taped to the top of a box (33.5 × 19 × 12 cm)
where mice were placed during the 30-min-long inhalation periods. The maximum concentration of
the EOs was calculated as 6.55 µL/L. Mice were randomized into eight groups: (1) the control group
treated with PBS i.t. and PO inhalation, (2) mice treated with LPS i.t. and PO inhalation, (3) PBS i.t.
and TO inhalation, (4) LPS i.t. and TO inhalation, (5) PBS i.t. and CO inhalation, (6) LPS i.t. and CO
inhalation, (7) PBS i.t. and LO inhalation, and (8) LPS i.t. and LO inhalation (n = 8–10/group).
4.4. Pulmonary Function Measurement
Respiratory functions were determined by unrestrained whole-body plethysmography (WBP)
(PLY3211, Buxco Europe Ltd., Winchester, UK) in conscious and spontaneously breathing animals 24 h
after PBS/LPS administration [48]. Baseline measurements were registered for 5 min with aerosolized
saline to determine the respiratory parameters, such as breathing frequency, tidal volume, minute
ventilation, time of inspiration and expiration, peak inspiratory and expiratory flow, and relaxation
time after 2 min of acclimation period. Enhanced pause (Penh), a calculated parameter ((expiratory
time/relaxation time)/(max. expiratory flow/max. inspiratory flow)) correlating with airway
hyperresponsiveness [48] was measured for 15-15 min after bronchoconstriction evoked by increasing
concentrations (11 and 22 mm) of aerosolized carbachol (carbamyl choline; Sigma, St. Louis, MO,
USA; dissolved in saline, 50 µL per mouse). Airway function parameters were registered every 10 s
and averaged by the BioSystem XA Software for Windows (Buxco Research Systems, Wilmington,
NC, USA).
4.5. Histopathological Assessment and Semiquantitative Scoring
Mice were anaesthetized, and their lungs were harvested after airway function measurements.
Left lungs were fixed in 4% formaldehyde, embedded in paraffin, sectioned with a microtome
(5–7 µm), and stained with hematoxylin-eosin, as well as periodic acid–Schiff reaction for the
visualization of the mucus-producing goblet cells. Inflammatory alterations were assessed by an
expert pathologist in a blinded manner with semiquantitative histopathological scoring. Scoring
parameters included the extent of perivascular edema (0–3), perivascular/peribronchial neutrophil
accumulation (0–3), infiltration of activated macrophages/mononuclear cells in the alveolar spaces
(0–2), and goblet cell hyperplasia of the bronchioles (0–2), as previously described [49,50]. A total
inflammatory score was also assessed ranging between 0 and 10 by adding the subscores of the
individual histopathological parameters.
4.6. Spectrophotometric Measurement of Myeloperoxidase (MPO) Activity
The activity of MPO enzyme correlates with the inflammatory infiltration of neutrophils and
macrophages and this biochemical marker refers to the inflammation. Spectrophotometric measurement
was made from the lung homogenates using H2O2-3,3′,5,5′-tetramethylbenzidine (TMB/H2O2), and the
MPO activity was compared to a human standard MPO preparation as described earlier [48].
All reagents were obtained from Sigma-Aldrich Ltd. (St. Louis, MO, USA).
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4.7. Statistical Analysis of Data
Respiratory parameters and MPO activity are expressed as mean ± SEM and analyzed with
one-way ANOVA followed by Tukey post-test. Penh was analyzed with two-way ANOVA followed
by Tukey post-test. Composite histopathological inflammatory score values were evaluated by
Kruskal–Wallis analysis followed by Dunn’s post-test. In all cases, p < 0.05 was accepted as significant.
Statistical analysis was performed in GraphPad Prism v6 software.
5. Conclusions
We conclude that the LPS-induced acute lung inflammation mouse model is an appropriate
mechanism model to investigate the effect of EO inhalation. TO and CO can be considered as potential
adjuvant treatment in airway inflammation, but the Ceylon type of LO use should be avoided.
Supplementary Materials: The Supplementary Materials are available online. Figure S1: Percentage changes of
respiratory parameters measured by unrestrained whole body plethysmography, Figure S2: Tidal volume and
minute ventilation normalized to body weight, Table S1: Body weights of the mice.
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